US insurers’ move to back vaccines sends ‘powerful’ message about safety of shots, experts say

Article excerpt

Major US insurers announced continued coverage for routine vaccines through 2027, a decision experts say sends a reassuring signal about vaccine safety as the Trump administration challenges the vaccine schedule and preventable diseases like measles and whooping cough spike. The insurance industry's backing of vaccination programs, a decision typically driven by cost-benefit analysis rather than politics, contrasts with the administration's skepticism. Scientists view the insurers' commitment as significant validation ahead of the November midterms, though questions linger about how policy shifts might affect vaccination rates and public health outcomes.